• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma 2023: Working with Patient Advocacy Groups

Article

Rebecca Vermeulen, VP Global Patient Networks, Product Development Medical Affairs for Roche discusses how they approach patient engagement.

Rebecca Vermeulen, VP Global Patient Networks, Product Development Medical Affairs for Roche discusses how the role of patient advocacy groups to improve patient engagement, how Roche organizes their relationships and the key takeaways for industry professionals.

Recent Videos
Related Content
Vaccines After COVID: Biopharma's Renewed Public Health and Commercial Push

Vaccines After COVID: Biopharma's Renewed Public Health and Commercial Push

Don Tracy, Associate Editor
November 8th 2024
Article

At the Financial Times’ Global Pharma and Biotech Summit 2024, a panel discussed the potential of mRNA technology in developing cancer vaccines amid distrust from the public.

Stock.adobe.com

Financial Times Global Pharma and Biotech Summit: The Impact of the Election

Mike Hollan
November 7th 2024
Article

How will President Trump’s return to office impact the pharma industry?

Strategies for the Looming Pharma Patent Cliff

Strategies for the Looming Pharma Patent Cliff

Don Tracy, Associate Editor
November 7th 2024
Article

At the Financial Times’ Global Pharma and Biotech Summit 2024, a panel discussed ways to prepare for the high number of incoming patent expiries and how to protect key drugs.

Stock.adobe.com

Financial Times Global Pharma and Biotech Summit: Taking Action on Innovation in Europe

Mike Hollan
November 7th 2024
Article

Padraic Ward discusses the innovation-environment in Europe.

Stock.adobe.com

Financial Times Global Pharma and Biotech Summit: Global Health

Mike Hollan
November 7th 2024
Article

David Reddy discusses negotiations on the global pandemic accord.

How to Bring World’s Most Innovative Treatments to Least Wealthy Places

How to Bring World’s Most Innovative Treatments to Least Wealthy Places

Don Tracy, Associate Editor
November 6th 2024
Article

At the Financial Times’ Global Pharma and Biotech Summit 2024, a panel discussed initiatives aimed at bringing cell and gene therapies to low- and middle-income countries.